Belpointe Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $817K | Sell |
6,464
-248
| -4% | -$32.7K | 0.03% | 560 |
|
|
2026
Q1 | $935K | Buy |
6,712
+602
| +10% | +$84.3K | 0.03% | 478 |
|
|
2025
Q4 | $750K | Buy |
6,110
+439
| +8% | +$53.4K | 0.03% | 536 |
|
|
2025
Q3 | $629K | Buy |
5,671
+124
| +2% | +$14.1K | 0.02% | 556 |
|
|
2025
Q2 | $615K | Sell |
5,547
-1,880
| -25% | -$200K | 0.03% | 503 |
|
|
2025
Q1 | $832K | Sell |
7,427
-1,100
| -13% | -$114K | 0.04% | 390 |
|
|
2024
Q4 | $674K | Buy |
8,527
+4,433
| +108% | +$399K | 0.04% | 436 |
|
|
2024
Q3 | $343K | Sell |
4,094
-9,049
| -69% | -$690K | 0.02% | 620 |
|
|
2024
Q2 | $902K | Buy |
13,143
+2,137
| +19% | +$143K | 0.06% | 300 |
|
|
2024
Q1 | $806K | Buy |
11,006
+558
| +5% | +$42.9K | 0.06% | 326 |
|
|
2023
Q4 | $846K | Sell |
10,448
-897
| -8% | -$69.8K | 0.07% | 245 |
|
|
2023
Q3 | $850K | Buy |
11,345
+3,632
| +47% | +$279K | 0.09% | 224 |
|
|
2023
Q2 | $594K | Sell |
7,713
-14,674
| -66% | -$1.17M | 0.06% | 268 |
|
|
2023
Q1 | $1.86M | Sell |
22,387
-7,267
| -25% | -$602K | 0.1% | 210 |
|
|
2022
Q4 | $2.55M | Sell |
29,654
-6,074
| -17% | -$481K | 0.15% | 133 |
|
|
2022
Q3 | $2.21M | Sell |
35,728
-329
| -0.9% | -$20.7K | 0.15% | 137 |
|
|
2022
Q2 | $2.23M | Buy |
36,057
+4,194
| +13% | +$260K | 0.15% | 145 |
|
|
2022
Q1 | $1.89M | Buy |
31,863
+9,063
| +40% | +$579K | 0.11% | 185 |
|
|
2021
Q4 | $1.66M | Buy |
22,800
+2,445
| +12% | +$168K | 0.1% | 199 |
|
|
2021
Q3 | $1.42M | Sell |
20,355
-424
| -2% | -$29.8K | 0.1% | 225 |
|
|
2021
Q2 | $1.43M | Buy |
20,779
+1,905
| +10% | +$127K | 0.1% | 217 |
|
|
2021
Q1 | $1.22M | Sell |
18,874
-3,107
| -14% | -$200K | 0.1% | 213 |
|
|
2020
Q4 | $1.28M | Buy |
21,981
+8,598
| +64% | +$519K | 0.12% | 212 |
|
|
2020
Q3 | $846K | Buy |
13,383
+242
| +2% | +$16.8K | 0.09% | 234 |
|
|
2020
Q2 | $1.01M | Sell |
13,141
-6,219
| -32% | -$477K | 0.13% | 167 |
|
|
2020
Q1 | $1.45M | Buy |
19,360
+6,322
| +48% | +$437K | 0.25% | 91 |
|
|
2019
Q4 | $847K | Buy |
13,038
+931
| +8% | +$60.6K | 0.11% | 208 |
|
|
2019
Q3 | $767K | Sell |
12,107
-2,283
| -16% | -$149K | 0.12% | 186 |
|
|
2019
Q2 | $972K | Buy |
14,390
+6,066
| +73% | +$399K | 0.19% | 120 |
|
|
2019
Q1 | $541K | Sell |
8,324
-3,577
| -30% | -$238K | 0.11% | 155 |
|
|
2018
Q4 | $744K | Buy |
11,901
+4,507
| +61% | +$315K | 0.19% | 116 |
|
|
2018
Q3 | $571K | Buy |
7,394
+1,007
| +16% | +$76.1K | 0.09% | 223 |
|
|
2018
Q2 | $452K | Buy |
6,387
+1,317
| +26% | +$93K | 0.13% | 183 |
|
|
2018
Q1 | $382K | Sell |
5,070
-1,016
| -17% | -$80.8K | 0.11% | 209 |
|
|
2017
Q4 | $436K | Buy |
6,086
+163
| +3% | +$12.4K | 0.1% | 261 |
|
|
2017
Q3 | $480K | Buy |
+5,923
| New | +$453K | 0.11% | 199 |
|
Other funds holding GILD
Belpointe Asset Management's GILD Position: Q2 2026 in Review
Belpointe Asset Management reduced its Gilead Sciences (GILD) stake by 3.7% in Q2 2026, selling an estimated $32.7K and leaving 6,464 shares worth $817K. The position accounts for 0.03% of the portfolio, ranked #560.
Belpointe Asset Management first reported a position in GILD in Q3 2017 and has held it in 36 quarters since. The position peaked at $2.55M in Q4 2022. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Belpointe Asset Management held 6,464 shares of Gilead Sciences worth $817K as of Q2 2026.
- Belpointe Asset Management sold 248 Gilead Sciences shares in Q2 2026, an estimated $32.7K.
- Gilead Sciences made up 0.03% of Belpointe Asset Management's portfolio in Q2 2026, its #560 holding.
- Belpointe Asset Management first reported a position in Gilead Sciences in Q3 2017 and has held it in 36 quarters since.
- Belpointe Asset Management's Gilead Sciences position peaked at $2.55M in Q4 2022.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.